Automatic Segmentation Ultrasound-based Radiomics Technology in Diabetic Kidney Disease

NCT ID: NCT05025540

Last Updated: 2022-02-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

499 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-06-01

Study Completion Date

2021-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Diabetic kidney disease is a common complication of diabetes and the main cause of end-stage renal disease. In this study, the investigator plan to enroll nearly 500 participant with/without DKD and to develop an automatic segmentation ultrasound based radiomics technology to differentiating participant with a non-invasive and an available way.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Ultrasound examination is a convenient, cheap and non-invasive method for kidney examination. However, the ability of conventional ultrasound to distinguish diabetic kidney disease from normal kidney is limited, and it is difficult to accurately distinguish between diabetic kidney disease and normal kidney only with the naked eye. In recent years, computer science has developed rapidly and artificial intelligence has been developing continuously. Much progress has been made in applying artificial intelligence in data analysis. Machine learning is a direction of generalized artificial intelligence, its main characteristic is to make the machine autonomous prediction and create algorithm, so as to achieve autonomous learning. kidney disease and deep learning are two different approaches in the field of machine learning. In this study, image omics and deep learning were used to analyze the images. Image omics extracts traditional image features, including shape, gray scale, texture, etc., and uses machine learning (pattern recognition) models to classify and predict, such as support vector machine, random forest, XGBoost, etc. Deep learning directly uses the convolutional network CNN to extract features, and completes classification and prediction in combination with the full connection layer, etc.

This study aims to explore the detection of diabetic kidney disease and its pathological degree based on automatic segmentation ultraound-based radiomics technology, mining of internal information of ultrasound images, and form a set of non-invasive monitoring of diabetic kidney disease complications development system, especially in primary medical institutions, has a broad clinical application prospect.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetic Kidney Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental group

Experimental group1:DKD patients with Type 2 diabetes patients with DKD Experimental group2:High level DKD patients with diabetic kidney disease Stage III and IV.

ultrasonic imaging

Intervention Type DIAGNOSTIC_TEST

Two-dimensional ultrasound images of the patient's kidneys were obtained by ultrasound imaging.

Control group

Control1:T2DM patients with Type 2 diabetes Control2:Low level DKD patients with diabetic kidney disease Stage I and II.

ultrasonic imaging

Intervention Type DIAGNOSTIC_TEST

Two-dimensional ultrasound images of the patient's kidneys were obtained by ultrasound imaging.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ultrasonic imaging

Two-dimensional ultrasound images of the patient's kidneys were obtained by ultrasound imaging.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with clinical diagnosis of T2DM and DKD were enrolled.
* patients with clear B mode ultrasound imaging in both side of kidney (left and right).
* No missing value in the vital clinical data such as eGFR and UACR.

Exclusion Criteria

* Patients with large kidney space occupying disease such as kidney renal cyst and tumor were excluded.
* Ultrasound images with severe shadow or incomplete kidney border were excluded.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pintong Huang

Role: STUDY_CHAIR

Department of Ultrasound, The Second Affiliated Hospital of Zhejiang University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The People's Hospital of Yingshang

Fuyang, Anhui, China

Site Status

Tianjin Third Central Hospital

Tianjin, Tianjin Municipality, China

Site Status

Department of Ultrasound, Second Affiliated Hospital, School of Medicine, Zhejiang University

Hangzhou, Zhejiang, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-0465

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Adipose Tissue & Uremia
NCT02902705 COMPLETED NA